Publications

  • A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.
    Boutault R, Peterlin P, Boubaya M, Sockel K, Chevallier P, Garnier A, Guillaume T, Le Bourgeois A, Debord C, Godon C, Le Bris Y, Theisen O, Kroschinsky F, Moreau P, Béné MC, Platzbecker U, Eveillard M.
    Br J Haematol. 2018;183(5):736-746 
  • Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
    Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A; (The International Working Group on Morphology of MDS).
    Br J Haematol. 2018;182(4):526-533 
  • Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.
    Valent P, Büsche G, Theurl I, Uras IZ, Germing U, Stauder R, Sotlar K, Füreder W, Bettelheim P, Pfeilstöcker M, Oberbauer R, Sperr WR, Geissler K, Schwaller J, Moriggl R, Béné MC, Jäger U, Horny HP, Hermine O.
    2018;103(10):1593-1603 
  • Evaluation of minimal residual disease in childhood ALL.
    Béné MC, Eveillard M
    Int J Lab Hematol. 2018 May;40 Suppl 1:104-108. doi: 10.1111/ijlh.12835. Review